Rapid changes in the biopharma industry are making it increasingly difficult to launch new products successfully. In this article, we review the five key levers for biopharma launch success and explain how they inform the creation of a high-performing product launch framework.
White Paper |
By Mucahit Agirtmis,Werum IT Solutions America, Inc.
This white paper discusses the unique biopharmaceutical supply chain challenges of cell and gene (C&G) therapy logistics and recommends forward-thinking solutions to address them. Successfully overcoming these logistics challenges is essential in order to scale up C&G therapies to treat large numbers of patients worldwide.
Process development is a critical enabler to bring safe, effective, sustainable products to market to address patient needs. In this webinar we will discuss our strategies for developing lentivirus and adeno associated virus (AAV) and the impact these early decisions can have on commercial readiness.